[go: up one dir, main page]

NO982853L - Aminoguanidin for behandling av NIDDM - Google Patents

Aminoguanidin for behandling av NIDDM

Info

Publication number
NO982853L
NO982853L NO982853A NO982853A NO982853L NO 982853 L NO982853 L NO 982853L NO 982853 A NO982853 A NO 982853A NO 982853 A NO982853 A NO 982853A NO 982853 L NO982853 L NO 982853L
Authority
NO
Norway
Prior art keywords
aminoguanidine
treatment
niddm
diabetes
type
Prior art date
Application number
NO982853A
Other languages
English (en)
Other versions
NO982853D0 (no
Inventor
Nicholas Charles Turner
Valerie Piercy
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9526330.7A external-priority patent/GB9526330D0/en
Priority claimed from GBGB9624914.9A external-priority patent/GB9624914D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO982853D0 publication Critical patent/NO982853D0/no
Publication of NO982853L publication Critical patent/NO982853L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Processing Of Solid Wastes (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Fremgangsmåte for behandling og/eller profylakse av Type II diabetes, hvilken fremgangsmåte omfatter administrering til et menneske eller annet pattedyr av en effektiv, ikke-toksisk, farmasøytisk akseptabel mengde av en inhibitor for proteinglykering, såsom aminoguanidin. Foretrukket tilveiebringer oppfinnelsen en fremgangsmåte for profylaktisk behandling av Type II diabetes, spesielt forsinkelse eller forhindring av forløpet fra hyperinsulinemi til hyperglykemi.
NO982853A 1995-12-22 1998-06-19 Aminoguanidin for behandling av NIDDM NO982853L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9526330.7A GB9526330D0 (en) 1995-12-22 1995-12-22 Novel method
GBGB9624914.9A GB9624914D0 (en) 1996-11-29 1996-11-29 Novel method
PCT/EP1996/005870 WO1997023203A1 (en) 1995-12-22 1996-12-18 Aminoguanidine for treating niddm

Publications (2)

Publication Number Publication Date
NO982853D0 NO982853D0 (no) 1998-06-19
NO982853L true NO982853L (no) 1998-06-19

Family

ID=26308373

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982853A NO982853L (no) 1995-12-22 1998-06-19 Aminoguanidin for behandling av NIDDM

Country Status (18)

Country Link
EP (1) EP0868176B1 (no)
JP (1) JP2000502667A (no)
KR (1) KR19990076594A (no)
CN (1) CN1209058A (no)
AT (1) ATE369847T1 (no)
AU (1) AU1307697A (no)
BR (1) BR9612250A (no)
CA (1) CA2240492A1 (no)
CZ (1) CZ198798A3 (no)
DE (1) DE69637209T2 (no)
ES (1) ES2292176T3 (no)
HU (1) HUP9903978A3 (no)
IL (1) IL124869A0 (no)
MX (1) MX9805099A (no)
NO (1) NO982853L (no)
PL (1) PL327471A1 (no)
TR (1) TR199801120T2 (no)
WO (1) WO1997023203A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20020625A1 (it) * 2002-12-17 2004-06-18 Sigma Tau Ind Farmaceuti Derivati di guanidine variamente sostituite, loro uso come medicamenti ad attivita' antidiabetica e/o antiobesita'.
CN100411615C (zh) * 2003-12-12 2008-08-20 上海第二医科大学附属瑞金医院 氨基胍对难愈创面的防治作用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665192A (en) * 1984-03-19 1987-05-12 The Rockefeller University 2-(2-furoyl)-4(5)-2(furanyl)-1H-imidazole
AU7316591A (en) * 1990-02-28 1991-09-18 Upjohn Company, The Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders
AU3876995A (en) * 1994-11-17 1996-06-17 McDougall, Greg Electric fan heater

Also Published As

Publication number Publication date
DE69637209D1 (de) 2007-09-27
NO982853D0 (no) 1998-06-19
EP0868176B1 (en) 2007-08-15
PL327471A1 (en) 1998-12-07
EP0868176A1 (en) 1998-10-07
KR19990076594A (ko) 1999-10-15
CZ198798A3 (cs) 1999-06-16
CN1209058A (zh) 1999-02-24
BR9612250A (pt) 1999-07-13
WO1997023203A1 (en) 1997-07-03
JP2000502667A (ja) 2000-03-07
DE69637209T2 (de) 2008-05-08
ATE369847T1 (de) 2007-09-15
IL124869A0 (en) 1999-01-26
ES2292176T3 (es) 2008-03-01
HUP9903978A2 (hu) 2000-03-28
CA2240492A1 (en) 1997-07-03
MX9805099A (es) 1998-10-31
HUP9903978A3 (en) 2001-01-29
AU1307697A (en) 1997-07-17
TR199801120T2 (xx) 1998-09-21

Similar Documents

Publication Publication Date Title
NO982311L (no) Sammensetninger og fremgangsmÕter for forhindring og behandling av oral muscositt
EE03737B1 (et) Taimset sterooli sisaldav produkt, selle valmistamismeetod ja kasutamine
NO961371L (no) Anvendelse av salt av minst et jordalkalimetall som inhibitor av -TNF, fremgangsmåte for kosmetisk behandling og kosmetisk preparat
NO996314D0 (no) Fremgangsmåte for behandling av tobakk for å redusere nitrosamin-innholdet og produkter som fremstilles derved
DE59509751D1 (de) Gegen hautalterung wirksame stoffe oder wirkstoffkombinationen und zubereitungen
NO981810D0 (no) Sammensetninger og fremgangsmÕter for behandling av tilstander ved bensvikt
NO962162D0 (no) Dipeptider som bevirker frigjöring av veksthormon
GB9407305D0 (en) Pharmaceutical compositions
NO992368L (no) FremgangsmÕter og forbindelser til inhibering av <beta>-amyloidfrigivning og/eller dets syntese
DK0833644T3 (da) Farmaceutisk og diætetiske sammensætninger til forebyggelse og behandling af gastrointestinale sygdomme
DE69526937D1 (de) Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen
AU7500794A (en) Novel use of dexmedetomidine
MX9401294A (es) Derivados de azolona sustituida
ZA945425B (en) 2-amino-4-phenyl-4-oxo-butyric acid derivatives
NO972426L (no) Metode for anvendelse av triarylethylenderivater ved behandling og forhindring av osteoporose
PL327818A1 (en) Novel medical application of ace inhibitor in treating dipeptic symptoms
NO20005981L (no) Anvendelse av 2-hydroksy-4-trifluorbenzosyrederivater som inhibitorer av aktivering av den nukleære transkripsjonsfaktor NF- <kappa>B
NO982853L (no) Aminoguanidin for behandling av NIDDM
ZA966954B (en) Anti-selectin antibodies for prevention of multiple organ failure after polytrauma and for prevention of acute organ damage after extracorporeal blood circulation.
NO952601L (no) Oligonukleotider for inhibering av ekspresjon av isoprenylprotein-transferaser
NO982854L (no) Nitrogenoksyd (NO) syntetase-inhibitor for Õ behandle eller forebygge type II diabetes
DE69424679D1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
AU2001262378A1 (en) Method for treating cryptorchidism
PT971714E (pt) Metodo utilizando inibidores ciclooxigenase-2 no tratamento e prevencao da demencia
UA29614A (uk) Спосіб профілактики і лікування турнікетного шоку

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application